B-cell-targeted therapies in systemic lupus erythematosus

@article{Chan2013BcelltargetedTI,
  title={B-cell-targeted therapies in systemic lupus erythematosus},
  author={Vera Sau-Fong Chan and Helen Hoi-Lun Tsang and Rachel Chun-Yee Tam and Liwei Lu and Chak-sing Lau},
  journal={Cellular and Molecular Immunology},
  year={2013},
  volume={10},
  pages={133-142}
}
Autoreactive B cells are one of the key immune cells that have been implicated in the pathogenesis of systemic lupus erythematosus (SLE). In addition to the production of harmful auto-antibodies (auto-Abs), B cells prime autoreactive T cells as antigen-presenting cells and secrete a wide range of pro-inflammatory cytokines that have both autocrine and paracrine effects. Agents that modulate B cells may therefore be of potential therapeutic value. Current strategies include targeting B-cell… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS